18889881171
Kalkine 0
countryflagUS
Kalkine Login

AAPL 221.4826 -1.0134% MSFT 389.31 -1.4804% NVDA 113.075 -6.3096% GOOGL 165.94 -2.7087% GOOG 167.985 -2.7808% AMZN 200.22 -2.6688% META 607.7499 -2.9634% AVGO 178.56 -5.1524% LLY 830.925 -2.5136% TSLA 270.5178 -6.1158% TSM 171.84 -5.0083% V 343.245 -0.399% JPM 250.25 -0.3504% UNH 514.545 0.2172% NVO 71.78 -2.4728% WMT 84.62 -0.1652% LVMUY 126.55 -2.0132% XOM 118.105 1.2994% LVMHF 635.0 -2.0757% MA 546.11 0.1743%
AAPL 221.4826 -1.0134% MSFT 389.31 -1.4804% NVDA 113.075 -6.3096% GOOGL 165.94 -2.7087% GOOG 167.985 -2.7808% AMZN 200.22 -2.6688% META 607.7499 -2.9634% AVGO 178.56 -5.1524% LLY 830.925 -2.5136% TSLA 270.5178 -6.1158% TSM 171.84 -5.0083% V 343.245 -0.399% JPM 250.25 -0.3504% UNH 514.545 0.2172% NVO 71.78 -2.4728% WMT 84.62 -0.1652% LVMUY 126.55 -2.0132% XOM 118.105 1.2994% LVMHF 635.0 -2.0757% MA 546.11 0.1743%

CVS Health Corp

Healthcare US CVS

66.95USD
0.47(0.71%)

Last update at 2025-03-26T18:50:00Z

Day Range

66.6367.47
LowHigh

52 Week Range

64.0790.82
LowHigh

Fundamentals

  • Previous Close 66.48
  • Market Cap101356.24M
  • Volume3813687
  • P/E Ratio12.06
  • Dividend Yield3.38%
  • EBITDA18343.00M
  • Revenue TTM346601.00M
  • Revenue Per Share TTM268.63
  • Gross Profit TTM 53456.00M
  • Diluted EPS TTM6.53

Analyst Recommendations

Financials

Income Statement

2018-12-312019-12-312020-12-312021-12-312022-12-310M50000M100000M150000M200000M250000M300000M
Total Revenue
Net Income

Balancesheet

2018-12-312019-12-312020-12-312021-12-312022-12-310M20000M40000M60000M80000M100000M120000M140000M160000M180000M200000M220000M
Total Assets
Total Liabilities

Change in Cash

2018-12-312019-12-312020-12-312021-12-312022-12-310M200M400M600M800M1000M1200M1400M1600M1800M2000M2200M

Total Operating Cash

2018-12-312019-12-312020-12-312021-12-312022-12-318000M9000M10000M11000M12000M13000M14000M15000M16000M17000M18000M19000M

Dividends Paid

2018-12-312019-12-312020-12-312021-12-312022-12-310M200M400M600M800M1000M1200M1400M1600M1800M2000M2200M2400M2600M2800M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 5628.00M 10420.00M 9770.00M 8997.00M 1406.00M
Minority interest 16.00M -12.00000M 13.00M -3.00000M -2.00000M
Net income 4311.00M 7910.00M 7179.00M 6634.00M -594.00000M
Selling general administrative 745.00M 36934.00M 35072.00M 33061.00M 21368.00M
Selling and marketing expenses - - - - -
Gross profit 54294.00M 52048.00M 49046.00M 45528.00M 31538.00M
Reconciled depreciation 4247.00M 4512.00M 4441.00M 4371.00M 2718.00M
Ebit 16251.00M 13193.00M 13911.00M 11987.00M 10174.00M
Ebitda 20498.00M 19676.00M 18558.00M 16482.00M 12892.00M
Depreciation and amortization 4247.00M 6483.00M 4647.00M 4495.00M 2718.00M
Non operating income net other 169.00M -270.00000M -1234.00000M 45.00M 4.00M
Operating income 16251.00M 13193.00M 13911.00M 11987.00M 4021.00M
Other operating expenses 306385.00M 277129.00M 254795.00M 244789.00M 184409.00M
Interest expense 2287.00M 2503.00M 2907.00M 3035.00M 2619.00M
Tax provision 1463.00M 2522.00M 2569.00M 2366.00M 2002.00M
Interest income 2287.00M 2503.00M 2907.00M 3035.00M 2619.00M
Net interest income -2287.00000M -2503.00000M -2907.00000M -3035.00000M -2619.00000M
Extraordinary items 0.00000M 0.00000M -9.00000M 0.00000M 100.00M
Non recurring 8336.00M 431.00M - - 6149.00M
Other items - - - - -
Income tax expense 1463.00M 2522.00M 2569.00M 2366.00M 2002.00M
Total revenue 322467.00M 292111.00M 268706.00M 256776.00M 194579.00M
Total operating expenses 38212.00M 37066.00M 35135.00M 33541.00M 21368.00M
Cost of revenue 268173.00M 240063.00M 219660.00M 211248.00M 163041.00M
Total other income expense net -10623.00000M -2773.00000M -4141.00000M -2990.00000M -6145.00000M
Discontinued operations - - -9.00000M -9.00000M -9.00000M
Net income from continuing ops 4165.00M 7898.00M 7201.00M 6631.00M -596.00000M
Net income applicable to common shares 4149.00M 7910.00M 7179.00M 6634.00M -594.00000M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 228275.00M 232999.00M 230715.00M 222449.00M 196456.00M
Intangible assets 24754.00M 29026.00M 31142.00M 33121.00M 36524.00M
Earning assets - - - - -
Other current assets 2685.00M 5292.00M 5277.00M 5113.00M 4581.00M
Total liab 156960.00M 157618.00M 161014.00M 158279.00M 137913.00M
Total stockholder equity 71015.00M 75075.00M 69389.00M 63864.00M 58225.00M
Deferred long term liab 3880.00M 6270.00M 6794.00M 7294.00M 7677.00M
Other current liab 47562.00M 5604.00M 5827.00M 4821.00M 4876.00M
Common stock 48193.00M 47377.00M 46513.00M 45972.00M 45440.00M
Capital stock 48193.00M 47377.00M 46513.00M 45972.00M 45440.00M
Retained earnings 56145.00M 54906.00M 49640.00M 45108.00M 40911.00M
Other liab 19948.00M 19663.00M 21033.00M 21351.00M 22460.00M
Good will 78150.00M 79121.00M 79552.00M 79749.00M 78678.00M
Other assets 7604.00M 9801.00M 51046.00M 9059.00M 8930.00M
Cash 12945.00M 9408.00M 7854.00M 5683.00M 4059.00M
Cash and equivalents 12945.00M 9408.00M 7854.00M 5683.00M 4059.00M
Total current liabilities 69736.00M 67807.00M 62017.00M 53303.00M 44009.00M
Current deferred revenue 3880.00M 43808.00M 37974.00M 32613.00M 28223.00M
Net debt 57787.00M 66591.00M 77188.00M 83319.00M 69370.00M
Short term debt 3456.00M 5851.00M 7078.00M 5377.00M 1985.00M
Short long term debt 1778.00M 4205.00M 5440.00M 3781.00M 1985.00M
Short long term debt total 70732.00M 75999.00M 85042.00M 89002.00M 73429.00M
Other stockholder equity -31858.00000M -28173.00000M -28178.00000M -28235.00000M -28228.00000M
Property plant equipment 12873.00M 12896.00M 12606.00M 32904.00M 11349.00M
Total current assets 65682.00M 60008.00M 56369.00M 50302.00M 45243.00M
Long term investments 21096.00M 23025.00M 20812.00M 17314.00M 15732.00M
Net tangible assets 71015.00M -33072.00000M -41305.00000M -49006.00000M -56977.00000M
Short term investments 2778.00M 3117.00M 3000.00M 2373.00M 2522.00M
Net receivables 27276.00M 24431.00M 21742.00M 19617.00M 17631.00M
Long term debt 50476.00M 51971.00M 59207.00M 64699.00M 71444.00M
Inventory 19090.00M 17760.00M 18496.00M 17516.00M 16450.00M
Accounts payable 14838.00M 12544.00M 11138.00M 10492.00M 8925.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity 300.00M 306.00M 312.00M 306.00M 318.00M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -1465.00000M 965.00M 1414.00M 1019.00M 102.00M
Additional paid in capital - - - - -
Common stock total equity 48193.00M 47377.00M 46513.00M 45972.00M 45440.00M
Preferred stock total equity - - - - -
Retained earnings total equity 56145.00M 54906.00M 49640.00M 45108.00M 40911.00M
Treasury stock -31858.00000M -28173.00000M -28178.00000M -28235.00000M -28228.00000M
Accumulated amortization - - - - -
Non currrent assets other 3968.00M 4714.00M 4624.00M 4600.00M 5046.00M
Deferred long term asset charges - - - - -
Non current assets total 162593.00M 172991.00M 174346.00M 172147.00M 151213.00M
Capital lease obligations 18478.00M 19823.00M 20395.00M 20522.00M -
Long term debt total 50476.00M 51971.00M 59207.00M 64699.00M 71444.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -1017.00000M -2717.00000M -3172.00000M -485.00000M 125.00M
Change to liabilities 4260.00M 5919.00M 5278.00M 3550.00M 2183.00M
Total cashflows from investing activities -5047.00000M -5261.00000M -5534.00000M -3339.00000M -43285.00000M
Net borrowings -4211.00000M -9267.00000M -5673.00000M -5320.00000M 38265.00M
Total cash from financing activities -10516.00000M -11356.00000M -8155.00000M -7850.00000M 36819.00M
Change to operating activities 7149.00M 3018.00M 2873.00M 1182.00M -149.00000M
Net income 4165.00M 7898.00M 7192.00M 6631.00M -596.00000M
Change in cash 614.00M 1648.00M 2176.00M 1659.00M 2395.00M
Begin period cash flow 12691.00M 11043.00M 5954.00M 4295.00M 1900.00M
End period cash flow 13305.00M 12691.00M 8130.00M 5954.00M 4295.00M
Total cash from operating activities 16177.00M 18265.00M 15865.00M 12848.00M 8865.00M
Issuance of capital stock - - - - -
Depreciation 4247.00M 4512.00M 4441.00M 4371.00M 2718.00M
Other cashflows from investing activities -1303.00000M -24.00000M 75.00M -397.00000M -41373.00000M
Dividends paid 2907.00M 2625.00M 2624.00M 2603.00M 2038.00M
Change to inventory -1435.00000M 735.00M -973.00000M -1075.00000M -1153.00000M
Change to account receivables -2971.00000M -2703.00000M -1510.00000M -2158.00000M -1139.00000M
Sale purchase of stock -3500.00000M 549.00M 257.00M 185.00M 688.00M
Other cashflows from financing activities -449.00000M 1523.00M 10100.00M 3809.00M 44935.00M
Change to netincome 2533.00M 549.00M 1073.00M 453.00M 6855.00M
Capital expenditures 2727.00M 2520.00M 2437.00M 2457.00M 2037.00M
Change receivables 2971.00M -2703.00000M -1510.00000M 2158.00M -1139.00000M
Cash flows other operating 16177.00M 1355.00M 364.00M 12848.00M -3.00000M
Exchange rate changes - - - - -
Cash and cash equivalents changes 614.00M 1648.00M 2176.00M 1659.00M 2399.00M
Change in working capital 7003.00M 3948.00M 3159.00M 1499.00M -112.00000M
Stock based compensation 447.00M 484.00M 400.00M 453.00M 280.00M
Other non cash items 2390.00M 1851.00M 1243.00M 548.00M 6488.00M
Free cash flow 13450.00M 15745.00M 13428.00M 10391.00M 6828.00M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CVS
CVS Health Corp		 0.47 0.71% 66.95 12.06 9.08 0.29 1.34 0.47 8.96
UNH
UnitedHealth Group Incorporated		 1.11 0.22% 514.54 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 3.60 0.85% 427.07 18.00 12.66 0.65 2.87 0.74
CI
Cigna Corp		 2.96 0.93% 319.80 30.25 10.09 0.39 2.10 0.50
HUM
Humana Inc		 -5.02 1.83% 268.75 19.16 14.60 0.56 3.37 0.53

Reports Covered

Stock Research & News

View All

Profile

CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corp

One CVS Drive, Woonsocket, RI, United States, 02895

Key Executives

Name Title Year Born
Ms. Karen Sue Lynch Pres, CEO & Director 1963
Mr. Shawn Michael Guertin Exec. VP & CFO 1964
Dr. Alan M. Lotvin M.D. Exec. VP & Pres of Pharmacy Services 1962
Mr. James David Clark Sr. VP, Controller & Chief Accounting Officer 1965
Mr. Tilak Mandadi Exec. VP & Chief Data, Digital and Technology Officer 1964
Mr. Larry McGrath Sr. VP of Bus. Devel. & Investor Relations NA
Mr. Thomas Michael Moriarty Exec. VP, Chief Policy & External Affairs Officer and Gen. Counsel 1964
Mr. David A. Falkowski Exec. VP & Chief Compliance Officer NA
Mr. Norman de Greve Chief Marketing Officer NA
Ms. Laurie P. Havanec Exec. VP & Chief People Officer 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.